Regeneron Pharmaceuticals
REGN
#129
Rank
$119.08 B
Marketcap
$1,081
Share price
-1.30%
Change (1 day)
49.77%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total debt

Total debt on the balance sheet as of March 2024 : $2.70 B

According to Regeneron Pharmaceuticals's latest financial reports the company's total debt is $2.70 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Regeneron Pharmaceuticals - Total debt on balance sheet (from 2001 to 2024)

Total debt by year

Year Total debt Change
2023-12-31$2.70 B0.06%
2022-12-31$2.70 B0.06%
2021-12-31$2.69 B0.15%
2020-12-31$2.69 B277.6%
2019-12-31$0.71 B0.76%
2018-12-31$0.70 B0.71%
2017-12-31$0.70 B46.22%
2016-12-31$0.48 B32.57%
2015-12-31$0.36 B-20.71%
2014-12-31$0.45 B-9.29%
2013-12-31$0.50 B10.33%
2012-12-31$0.45 B5%
2011-12-31$0.43 B172.16%
2010-12-31$0.16 B46.79%
2009-12-31$0.10 B2040.62%
2008-12-31$5.09 M-97.45%
2007-12-31$0.20 B0%
2006-12-31$0.20 B0%
2005-12-31$0.20 B0%
2004-12-31$0.20 B-6.46%
2003-12-31$0.21 B6.83%
2002-12-31$0.20 B-0.21%
2001-12-31$0.20 B

Total debt for similar companies or competitors

Company Total debt differencediff. Country
$64.02 B 2,268.22%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.30 B-51.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.94 B 156.97%๐Ÿ‡บ๐Ÿ‡ธ USA
$33.63 B 1,144.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$27.28 B 909.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$20.36 B 653.42%๐Ÿ‡ซ๐Ÿ‡ท France